Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade

Molecular Cancer Therapeutics (2005) - Comments
pubmed: 16227402 doi: 10.1158/1535-7163.mct-05-0068 issn: 1535-7163 issn: 1538-8514

Yijiang Shi, Huajun Yan, Patrick Frost, Joseph Gera, Alan Lichtenstein